greeksoup/ stock research

Molina Healthcare (MOH) Q3 FY2024 earnings: revenue $10.3 billion, up 21.0% on the year

Molina Healthcare, Inc. (MOH) reported revenue of $10.3 billion for Q3 FY2024, the quarter ended 30 September 2024, up 21.0% on the same quarter a year earlier. Net income was $326 million, up 33.1% on the year, and diluted earnings per share $5.65. The figures are the company's own, from the 10-Q it filed with the SEC on 24 October 2024.

Revenue$10.3 billionup 21.0%
Net income$326 millionup 33.1%
Diluted EPS$5.65
QuarterQ3 FY2024ended 30 September 2024

The quarter, against the one before and a year earlier

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Revenue10,3409,8808,548+21.0%
Cost of revenue8,6438,3687,306+18.3%
Gross profit1,6971,5121,242+36.6%
Gross margin16.4%15.3%14.5%
Operating income467434359+30.1%
Operating margin4.5%4.4%4.2%
Interest expense29.028.027.0+7.4%
Pre-tax income438406332+31.9%
Income tax11210587.0+28.7%
Effective tax rate25.6%25.9%26.2%
Net income326301245+33.1%
Net margin3.2%3.0%2.9%
Diluted EPS$5.65$5.17$4.21+34.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Operating cash flow873-219949-8.0%
Capital expenditure35.027.026.0+34.6%
Free cash flow838-246923-9.2%
Free cash flow margin8.1%-2.5%10.8%
Cash from investing-48.053.0-280n/a
Cash from financing-36412.0-6.0n/a
Depreciation and amortisation47.046.042.0+11.9%
Share-based compensation30.032.033.0-9.1%
Buybacks5000.00.0n/a
Diluted shares, weighted58m58m58m-0.7%
Shares outstanding at period end57m59m58m-1.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Shareholders' equity4,7704,8433,879+23.0%
Debt2,3322,1812,179+7.0%
Finance lease liabilities197203199-1.0%
Other liabilities8,4597,9588,613-1.8%
Total liabilities and equity15,75815,18514,870+6.0%
Investments4,4824,3474,111+9.0%
Cash and equivalents4,7324,3545,565-15.0%
Receivables3,2593,2312,460+32.5%
Other assets3,2853,2532,734+20.2%
Total assets15,75815,18514,870+6.0%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue8,5489,0489,9319,88010,34010,49911,14711,42711,47711,37510,79610,874
Cost of revenue7,3067,4548,4148,3688,6439,0039,4799,82910,04410,1369,2709,440
Gross profit1,2421,5941,5171,5121,6971,4961,6681,5981,4331,2391,5261,434
Gross margin15%18%15%15%16%14%15%14%12%11%14%13%
Operating income359316426434467380433373137-16283.0145
Operating margin4%3%4%4%5%4%4%3%1%-1%1%1%
Interest expense27.027.027.028.029.034.043.048.049.052.054.054.0
Pre-tax income33228939940643834639032588.0-21429.091.0
Tax rate26%25%25%26%26%27%24%22%10%n/a52%34%
Net income24521630130132625129825579.0-16014.060.0
Net margin3%2%3%3%3%2%3%2%1%-1%0%1%
Diluted EPS$4.21$3.70$5.17$5.17$5.65$4.44$5.45$4.75$1.51-$3.15$0.27$1.19
Operating cash flow949-690214-219873-224190-302-125-2981,082-294
Capital expenditure26.0n/a27.027.035.011.022.042.038.0n/a27.030.0
Free cash flow923n/a187-246838-235168-344-163n/a1,055-324
Buybacks0.0n/a0.00.05005005000.05000.00.00.0
Shares outstanding58m58m59m59m57m56m54m54m51m51m52m52m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2024, filed 24 October 2024, accession 0001179929-24-000151: the filing on EDGAR. All of Molina Healthcare, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install